Volume 17, Issue 9 pp. 1271-1278
Article
Full Access

Antigen presentation and tumor cytotoxicity by interferon-γ-treated microglial cells

Karl Frei

Corresponding Author

Karl Frei

Section of Clinical Immunology and Department of Neurosurgery, University Hospital, Zurich

Section of Clinical Immunology, University Hospital, Haeldeliweg 4, CH-8044 Zurich, SwitzerlandSearch for more papers by this author
Christine Siepl

Christine Siepl

Section of Clinical Immunology and Department of Neurosurgery, University Hospital, Zurich

Recipient of a fellwoship from the Deutsche Forschungsgemeinschaft.

Search for more papers by this author
Peter Groscurth

Peter Groscurth

Institute of Anatomy, Division of Cell Biology, University of Zurich, Zurich

Search for more papers by this author
Stefan Bodmer

Stefan Bodmer

Section of Clinical Immunology and Department of Neurosurgery, University Hospital, Zurich

Search for more papers by this author
Cornelia Schwerdel

Cornelia Schwerdel

Section of Clinical Immunology and Department of Neurosurgery, University Hospital, Zurich

Search for more papers by this author
Adriano Fontana

Adriano Fontana

Section of Clinical Immunology and Department of Neurosurgery, University Hospital, Zurich

Search for more papers by this author
First published: 1987
Citations: 517

Abstract

In this study microglial cells isolated from brain cell cultures of newborn mice were characterized and investigated for morphology, their responses to growth factors and their functional properties. The microglial cells were phagocytic, contained nonspecific esterase activity and expressed Fc (IgG1/2b) and type-3 complement receptors. Scanning electron microscopy revealed that in analogy to brain tissue two types of microglial cells are present in the cultures: the ameboid and the ramified type which both display similar appearance by transmission electron microscopy. Interleukin 3 and the granulocyte-macrophage colony-stimulating factor were potent growth factors for the cultured microglial cells. The cells were negative for class II antigens (Ia) of the major histocompatibility antigen complex. However, upon treatment with interferon-γ (IFN-γ) microglial cells became Ia+ and functioned as antigen-presenting cells when tested on ovalbumin-specific Ia-restricted helper T cells. Furthermore, microglial cells exposed to IFN-γ and endotoxin developed tumor cell cytotoxicity and produced tumor necrosis factor α. Taken together, microglial cells share the characteristics of cells of the macrophage lineage.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.